Evidence map›Paper›PMID 31693736›Full record

ArticleThe journals of gerontology. Series A, Biological sciences and medical sciences2020

Association of Blood Chemistry Quantifications of Biological Aging With Disability and Mortality in Older Adults.

Daniel C Parker, Bryce N Bartlett, Harvey J Cohen, Gerda Fillenbaum, Janet L Huebner, Virginia Byers Kraus, Carl Pieper, Daniel W Belsky

Open access · greenAbstract read
In one paragraph

Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it, 94 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Racial and Social Inequities in Weathering: the ELSA-Brasil Cohort.Journal of racial and ethnic health disparities · 2025
    Article
  11. Article
  12. Article
  13. No winners or losers: clinical chemistry-based biological aging metrics perform similarly across cohorts and health outcomes.The journals of gerontology. Series A, Biological sciences and medical sciences · 2025
    Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Daniel C ParkerDepartment of Medicine, Division of Geriatrics, Duke University School of Medicine, Durham, North Carolina.
Bryce N BartlettDepartment of Sociology, Duke University, Durham, North Carolina.
Harvey J CohenDepartment of Medicine, Division of Geriatrics, Duke University School of Medicine, Durham, North Carolina.
Gerda FillenbaumDuke University Center for the Study of Aging and Human Development, Durham, North Carolina.
Janet L HuebnerDuke Molecular Physiology Institute, Duke University, Durham, North Carolina.
Virginia Byers KrausDuke University Center for the Study of Aging and Human Development, Durham, North Carolina.
Carl PieperDuke University Center for the Study of Aging and Human Development, Durham, North Carolina.
Daniel W BelskyDepartment of Epidemiology, Columbia University Mailman School of Public Health, New York.
Duke University · USColumbia University · US

Funding

Resource Core 3 - Metabolomics CoreP30AG028716 · NIA · DUKE UNIVERSITY · PI Sarah B. Peskoe · 2006 to 2026
$24.6M
BEHAVIOR AND PHYSIOLOGY IN AGINGT32AG000029 · NIA · DUKE UNIVERSITY · PI Maria Marquine · 1985 to 2026
$9.3M
Epigenetic Mechanisms Promoting LongevityR01AG054840 · NIA · DUKE UNIVERSITY · PI KRAUS, VIRGINIA · 2018 to 2022
$3.4M
A pilot study to advance translation of molecular signatures of biological agingR21AG054846 · NIA · DUKE UNIVERSITY · PI BELSKY, DANIEL WALKER · 2017 to 2018
$437k
NIA NIH HHS P30 AG028716NIA NIH HHS R01 AG054840NIA NIH HHS R21 AG054846NIA NIH HHS T32 AG000029
6 · The paper itself

Abstract

Quantification of biological aging has been proposed for population surveillance of age-related decline in system integrity and evaluation of geroprotective therapies. However, methods of quantifying biological aging have been little studied in geriatric populations. We analyzed three clinical-biomarker-algorithm methods to quantify biological aging. Klemera-Doubal method Biological Age and homeostatic dysregulation algorithms were parameterized from analysis of U.S. National Health and Nutrition Examination Surveys (NHANES) data (N = 36,207) based on published methods. Levine method Biological Age was adapted from published analysis of NHANES data. Algorithms were applied to biomarker data from the Duke Established Populations for Epidemiologic Studies of the Elderly (Duke-EPESE) cohort of older adults (N = 1,374, aged 71-102 years, 35% male, 52% African American). We tested associations of biological aging measures with participant reported Activities of daily living (ADL), instrumental activities of daily living (IADL) dependencies, and mortality. We evaluated the sensitivity of results to the demographic composition of reference samples and biomarker sets used to develop biological aging algorithms. African American and white Duke-EPESE participants with more advanced biological aging reported dependence in more ADLs and IADLs and were at increased risk of death over follow-up through 2017. Effect sizes were similar across algorithms, but were strongest for Levine method Biological Age (per-quintile increase in ADL incidence rate ratio = 1.25, 95% confidence interval [1.17-1.37], IADL incidence rate ratio = 1.23 [1.15-1.32], mortality hazard ratio = 1.12 [1.08-1.16]). Results were insensitive to demographic composition of reference samples, but modestly sensitive to the biomarker sets used to develop biological aging algorithms. Blood-chemistry-based quantifications of biological aging show promise for evaluating the effectiveness of interventions to extend healthy life span in older adults.

Indexed as

MortalityPersons with DisabilitiesAgedAged, 80 and overAgingAlgorithmsBiomarkersBlack or African AmericanFemaleHumansMaleNutrition SurveysRisk FactorsSex FactorsWhite PeopleBiomarkersAge-related pathologyBioinformaticsHuman agingMortality

Identifiers

PMID31693736
PMCPMC7494046
OpenAlexW2982729357

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.